Nippon Chemiphar : Highlights of second quarter FY2021 business results. (pdf, 820KB)

（TSE 4539）

Highlights of Second Quarter

FY2021 Business Results

(Year ending March 31, 2022)

1

Contents

I. Summary of Results ………………………… 3

II. Management Strategy…………………………. 9

2

I. Summary of Results

3

Sales, Income

									(¥mn)
		FY2020			FY2021
						YOY
		2Q	% of	2Q	% of		Change	Fullyear	Progress
		Amount	Sales	Amount	Sales	Amount	(%)	Forecast	Rate (%)
	Net Sales	14,832	100.0	15,575	100.0	―	―	31,000	50.2
	Pharmaceutical products	14,569	98.2	15,115	97.0	―	―	―	―
	Others	262	1.8	460	3.0	―	―	―	―
	Cost of sales	9,446	63.7	11,265	72.3	―	―	―	―
					8.6p
	SG&A expenses	5,575	37.6	4,103	26.3	―	―	―	―
					(11.3p)
	Operating profit/loss	(189)	―	206	1.3	―	―	350	58.9
	Profit/loss before income taxes
	and minority interests	346	―	258	1.7	―	―	―	―
	Profit/loss attributable to
	owners of the parent	(257)	―	228	1.5	―	―	80	286.2

(Reference) Year-on-Year Comparisons Utilizing Previous Accounting Standards

				(mn)
	FY2020	FY2021	YOY*
	2Q	2Q
	Amount	Amount*	Change	%
Net Sales	14,832	17,110	2,277	15.4
Pharmaceuticals	14,569	16,675	2,105	14.5
Others	262	434	172	65.6

Note:

We applied "the Accounting Standards for Revenue Recognition (ASBJ Statement No. 29)" from the FY2021.

Therefore, year-on year rate from the actual results for the FY2020 before the application of the standards, etc. is not stated.

4

Reason for Rising Cost of Sales Rario

13% impact to total pharmaceutical price by NHI price revision

Reducing the cost of APIs and products purchased

8.4p
	Aggressive promotion of high-profit products

			(1.0p)	(3.2p)	Improve operation rate at factory
					(2.0p)	YOY
	6.4p					2.2p
						8.6p
						72.3%
63.7%
2021年3月期	会計基準	薬価改定	Upshot of		稼働率及び
	Adopt new	Effect of	原価	セールス	Operation 2022年3月期
FY2Q第2四半期FY2020	変更	NHI price	低減策	Improved	その他	Cost of
ミックス改善	第2四半期
	accounting	our cost	sales mix	ratio,	sales ratio
	standard	revisions	cutting	others
			FY2Q FY2021

Without impact of new accounting standard, cost of sales ratio up only 2.2 percentage points by our effort to improve sales mix or cost cutting.

5

5